Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
46.05 (1y: +33%)
Market Cap 76.95 B P/E(ttm) 52.60
Enterprise Value 82.31 B P/B 5.60
BMY- NYSE (USA)
Bristol-Myers Squibb Company
  • Currently 1/5
Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$46.05
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M76,954Revenue $M16,201Net Margin (%)11.1Z-Score3.9
Enterprise Value $M82,315EPS $0.9Operating Margin %12.8F-Score4
P/E(ttm))52.6Cash Flow Per Share $2.8Pre-tax Margin (%)13.3Higher ROA y-yY
Price/Book5.610-y EBITDA Growth Rate %1.6Quick Ratio1.8Cash flow > EarningsY
Price/Sales4.85-y EBITDA Growth Rate %-3.4Current Ratio1.1Lower Leverage y-yN
Price/Cash Flow11.7y-y EBITDA Growth Rate %-78.9ROA % (ttm)5.5Higher Current Ratio y-yN
Dividend Yield %3.0Insider Buy (3m)0ROE % (ttm)14.4Less Shares Outstanding y-yN
Payout Ratio %157Shares Outstanding M1,637ROI % (ttm)16.3Gross Margin Increase y-yN

Gurus Latest Trades with BMY

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Number of guru portfolios checked: 51.
TickerDate Action
 Impactdown Price Range
(Average)* 		Current Price Change from Average Comment Current Shares
BMY2013-03-31 Sold Out -0.64%$32.59 - $41.19
($36.62)		 $ 46.0526%Sold Out0
BMY2012-12-31 Reduce-0.2%$30.81 - $34.38
($32.89)		 $ 46.0540%Reduce -25%750,000
BMY2011-12-31 Reduce-0.5%$30.15 - $35.29
($32.54)		 $ 46.0542%Reduce -50%1,000,000
BMY2011-06-30 Add0.23%$26.46 - $29.33
($28.07)		 $ 46.0564%Add 33.33%2,000,000
BMY2011-03-31 Reduce-0.88%$24.97 - $27.29
($25.92)		 $ 46.0578%Reduce -57.14%1,500,000
BMY2010-12-31 Add0.21%$25.24 - $27.51
($26.5)		 $ 46.0574%Add 16.67%3,500,000
BMY2010-09-30 Buy 1.13%$24.65 - $27.93
($26.17)		 $ 46.0576%New holding, 3000000 sh.3,000,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.
Total Records: 7

BMY is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BMY Ray Dalio 2013-03-31181,1400.010.07+267.87%
BMY Vanguard Health Care Fund 2013-03-3117,948,5611.12.9+49.53%
BMY Mario Gabelli 2013-03-31951,9950.060.25+5.77%
BMY Prem Watsa 2013-03-317,00000.01
BMY Jean-Marie Eveillard 2013-03-3116,52000
BMY Dodge & Cox 2013-03-3180,12100
BMY James Barrow 2013-03-31000Sold Out
BMY John Hussman 2013-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


BMY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
von Autenried PaulSVP, Enterp. Services & CIO 2013-06-10Sell25,000$47.24-0.83view
Caldarella Joseph CSVP & Controller 2013-06-06Sell26,275$46.530.69view
Elicker John ESVP Pub Affairs & Inv Relation 2013-06-05Sell25,997$46.331.12view
Moed Samuel JSVP, Strat Plan & Analysis 2013-06-04Sell58,898$47.38-1.12view
ANDREOTTI LAMBERTOCEO 2013-06-04Sell100,000$47.74-1.86view
SIGAL ELLIOTEVP, CSO & President R&D 2013-06-03Sell83,647$48.18-2.76view
Cazala Beatrice JEVP Commercial Operations 2013-05-31Sell91,282$47-0.32view
Caforio GiovanniPres., US Pharmaceuticals 2013-05-31Sell10,538$47.06-0.45view
Cazala Beatrice JEVP Commercial Operations 2013-05-30Sell22,000$47-0.32view
SIGAL ELLIOTEVP, CSO & President R&D 2013-05-30Sell143,521$47.23-0.8view

Press Releases about BMY :

Quarterly/Annual Reports about BMY:

News about BMY:

Articles On GuruFocus.com
Johnson & Johnson (JNJ) - A must own dividend stock May 31 2013 
Deep Value Investor James Barrow Unloads Six May 28 2013 
Johnson & Johnson (JNJ) Dividend Stock Analysis May 23 2013 
Abbvie Inc. (ABBV) Dividend Stock Analysis Mar 22 2013 
10 Best Dividend Paying Drug Manufacturing Stocks Mar 02 2013 
Abbott Laboratories (ABT) Dividend Stock Analysis Dec 27 2012 
Stocks to Buy on Dips: Teva Dec 27 2012 
Abbott Laboratories: Quality Dividend Aristocrat for Long Term Dividends Dec 21 2012 
This Dividend Stock Traces Its Origin Back to Oldsmobile Dec 10 2012 
Becton, Dickinson and Co. (BDX) Dividend Stock Analysis Nov 23 2012 

More From Our Partners
Simcere Ties Up with Bristol-Myers - Analyst Blog Jun 17 2013 - ZACKS

Add Notes, Comments or Ask Questions

Please log in first

Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK